AAA April 2012 – Page 11

Corporates pour $22.7m into Belgian uni spin-out

Pharmaceutical groups Boehringer Ingelheim and Shire as well as Japanese conglomerate Mitsui’s corporate venturing unit and ATMI have helped Promethera Biosciences, a  Belgium-based cell therapy company, raise €17m ($22.7m). The companies were joined in the series B round on Wednesday by Belgium-based venture capital firm SambrInvest. The Walloon Region, which has backed the company since… Continue reading Corporates pour $22.7m into Belgian uni spin-out